pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Vaccines 103

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 103

pharmaphorum

SEPTEMBER 9, 2022

Rising global temperatures will, for example, enhance the spread of mosquito-borne diseases like malaria and Zika, increasing the need for effective vaccines. In 2019, the pharmaceutical industry produced 48.55 But preparing to adapt to the phenomenon presents an opportunity as well as a challenge. Responsibility .

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies Vaccines 96

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world. About the author.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 110

pharmaphorum

AUGUST 5, 2022

The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace. 1 Despite the increasing amount of venture capital flowing to biotech companies, total investments in such businesses nearly doubling between 2019 and 2021. About the Author.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

NOVEMBER 4, 2022

Goods were largely delivered on time, and at a low cost, benefitting both companies and consumers. According to GlobalData’s Social Media Analytics, supply chains were mentioned on Reddit and Twitter 1,908 times in 2019. As such, few people were focused on them. By 2021, social media mentions of supply chains reached 25,636.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

pharmaphorum

JANUARY 22, 2021

More than 100,000 MS patients were included in the data set, defined as patients with two or more MS-related medical claims or one or more MS-related medical claims plus a related pharmacy claim identified between January 2019 and June 2020. These changes, initially presumed to be temporary, may continue beyond the pandemic.

Specialty Pharmacies 96

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 96

NY Times

JUNE 2, 2021

We need more vaccines, fast. Is forcing pharmaceutical companies to share their intellectual property the answer?

Vaccines 55

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunity 55

pharmaphorum

APRIL 16, 2021

Even with the vaccine roll-out, further waves of COVID infection and lockdowns mean these vital drivers of launch performance remain impacted in 2021, and even beyond. This wasn’t the case in Germany, where a resilient system meant that productivity in terms of HTA decisions was higher in 2020 than the historic average from 2015-2019.

Pharmaceutical Companies 80

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 80

European Pharmaceutical Review

DECEMBER 12, 2023

Pharmaceutical companies such as Sanofi and AstraZeneca are currently conducting several high-potential clinical development programmes in oncology in collaboration with Innate Pharma. Innate Pharma has also partnered with Takeda to develop an antibody drug conjugate (ADC). percent, reaching even 57.1 percent in the skin.

Immunity 104

Immunity Immunization Chemotherapy Pharmaceutical Companies 104

pharmaphorum

AUGUST 13, 2020

The 2019 Edelman Global Trust Barometer showed levels of mistrust in business to be stratospheric, at their highest point ever. or profits) according to the Chronicle of Philanthropy , yet still, the organisation doesn’t even appear on the 2019 Axios Harris poll of top 100 reputation ranking. Non-pharma brands leading by example.

Health and Personal Care Stores 90

Health and Personal Care Stores Vaccines Communication Diabetes 90

pharmaphorum

OCTOBER 12, 2022

In 2019, Del Bourgo and co-founder Julien Cottineau launched Whitelab Genomics and its AI platform dedicated to supporting the discovery and design of genomic therapies. The software applies machine learning to patient data to support therapeutics companies as they develop novel treatments. About Whitelab Genomics.

Immunity 98

Immunity Immunization Drug Development Vaccines 98

PharmaShots

MARCH 9, 2023

She has also been awarded Crain’s Notable Women in Healthcare in 2019. Award & Nominations: For her contributions to the pharmaceutical sector and business, Emma received the rank of Dame Commander (DBE) in the 2020 Queen's Birthday Honours. LinkedIn Total experience: 31 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Pharmaceutical Technology

DECEMBER 27, 2022

The Covid-19 pandemic pushed most markets into free fall, leading to increased wariness for completing large mergers and acquisitions (M&As) in the pharmaceutical sector. In 2022, Russia’s war on Ukraine struck the supply chain, eventually slowing manufacturing and causing shortages for multiple pharmaceutical companies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

Diabetes 58

Diabetes Immunity Immunization Pharmaceutical Companies 58

pharmaphorum

DECEMBER 2, 2020

Similarly, in 2019 Pfizer announced a deal to merge its Upjohn generics business with Mylan, creating a combined company called Viatris. In 2014 the company made an offer of around $100 billion to acquire UK firm AstraZeneca (which at the time was going through a rough patch ).

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

pharmaphorum

JANUARY 5, 2021

One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible. Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

SEPTEMBER 9, 2021

The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development. COVID-19 also put global supply chains in the spotlight, as industry looked to remove obstacles and speed the delivery of material crucial to vaccine development processes.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

JANUARY 30, 2023

For 2019–23, this was capped at 2% per year. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector. At this punitive percentage, VPAS member companies may be required to pay back up to GBP3.3 billion ($4.1 billion) to the NHS.

Biosimilars 97

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

PharmaShots

MAY 1, 2023

The pharmaceutical industry is an integral part of the healthcare system. To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Diabetes Vaccines 40

PharmaShots

MAY 1, 2023

The pharmaceutical industry is an integral part of the healthcare system. To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Diabetes Vaccines 40

PharmaShots

FEBRUARY 21, 2023

Market Cap: $82.80M Founded Year: 2001 Total Employees: ~70 Headquarters: Kawasaki, Japan Stock Exchange: TYO OncoTherapy Science is a biotech company focused on developing novel molecular-targeted anti-cancer drugs using its own technologies.

Dosage 56

Dosage Labelling Immunity Immunization 56

Express Pharma

JANUARY 12, 2024

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. The time for commencing manufacturing or production was extended to 31 March 2024 by the Finance Act, 2022.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Model: Inspired by the industry 4.0 model, the pharma 4.0 compared to 2015.

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

AUGUST 16, 2021

Nearly every element of the clinical trial design, data collection, analysis and approvals has been shortened and this helped ensure the swift rollout of safe and effective vaccines.”. In 2019, Formedix collaborated with a UK-based consortium interested in observing early safety data. About the interviewee.

Documentation 98

Documentation Vaccines Packaging Pharmaceutical Companies 98

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. Launches, therefore, were happening.

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 58

Eye on FDA

MAY 4, 2020

Naturally it is not up to the pharmaceutical, biotech and device sector to solve all of these problems, but there may be a very real expectation that they are huge part of the solution in areas where they have the ability to make the greatest impact. When everything else is somewhat broken, the industry will likely still be standing tall.

Pharmaceutical Companies 45

Pharmaceutical Companies Pharmaceutical Companies Hospitals Vaccines 45

pharmaphorum

JANUARY 6, 2022

IQVIA Institute models global cumulative spend on COVID-19 vaccines to be a base case of $251bn to 2026 , with spend on COVID-19 treatments, including the new oral agents and treatments of post-viral syndromes, likely to add significant incremental spend. Dealmaking in RNA Therapeutics rose 13-fold from 2019 to 2020.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

FEBRUARY 16, 2022

The Life Sciences Vision also identified seven therapeutic areas that are priorities for the government: treatments for neurodegenerative disorders, cancer immunotherapies, novel vaccines, cardiometabolic therapies, treatments for respiratory disorders, therapies for multi-system ageing and treatments for mental illness. About the authors.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

This was higher than the number of approvals in 2019 and 2020. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52